Voloridge Investment Management
CELL

Voloridge Investment Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Voloridge Investment Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-43,438
Closed -$790K – 1789
2021
Q4 		$790K Sell
43,438
-117,996
-73% -$2.55M ﹤0.01% 1326
2021
Q3 		$3.16M Buy
+161,434
New +$6.14M 0.02% 869
2021
Q2 		– Sell
-44,215
Closed -$2.22M – 1841
2021
Q1 		$2.22M Buy
+44,215
New +$3.01M 0.02% 792

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Voloridge Investment Management's CELL Position: Q1 2022 in Review

Voloridge Investment Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 43,438 shares — an estimated $790K sold.

Voloridge Investment Management first reported a position in CELL in Q1 2021 and held it in 3 quarters. The position peaked at $3.16M in Q3 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Voloridge Investment Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 43,438 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $790K.
  • Voloridge Investment Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Voloridge Investment Management's PhenomeX Inc. Common Stock position peaked at $3.16M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.